Alloprevotella tannerae

Information

Microbe Identification

Alloprevotella tannerae

Microbe id: PMDBM2020390
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Alloprevotella tannerae [76122]
Taxonomy Genus: Alloprevotella [1283313]
Taxonomy Family: Prevotellaceae [171552]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Alloprevotella tannerae

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
NADH dehydrogenase I Bacteroides sp.Energy-capturing-relatedNADH dehydrogenase IPMID: 26443736
Glycine cleavage C. sticklandiiGlycineGlycine cleavagePMID: 8375392
PFOR II pathway B. thetaiotaomicronPyruvatePFOR II pathwayPMID: 32301184
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067
Fumarate to succinate B. thetaiotaomicronFumarateFumarate to succinatePMID: 28049145

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Alloprevotella tannerae


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RRE-containingPMID: 34019648
Unclassified gene clustern.a.ResorcinolPMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Alloprevotella tannerae distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Alloprevotella tannerae in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Alloprevotella tannerae

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗-3.6786879665402916S
Depression, Postpartum PRJNA637228🔗3.5704181713746516S
Diabetes Mellitus, Type 2 PRJDB5860🔗-4.0525832188779316S
Diabetes Mellitus, Type 2 PRJNA646010🔗3.0949064699688416S
Diarrhea PRJNA317326🔗-3.033937449028516S
Rett Syndrome PRJNA687633🔗-3.4908641803681816S
Colorectal Neoplasms PRJNA731589🔗2.02381173808666mNGS
Colorectal Neoplasms PRJNA961076🔗2.32517223994636mNGS
Colorectal Neoplasms PRJNA763023🔗2.38486915446897mNGS
Colorectal Neoplasms PRJNA763023🔗2.78157875030495mNGS
Colorectal Neoplasms PRJNA1126038🔗3.0135695074241616S
Colorectal Neoplasms PRJNA888860🔗3.01828041694491mNGS
Colorectal Neoplasms PRJNA888860🔗3.16435425617937mNGS
Colorectal Neoplasms PRJNA1167935🔗3.37228298783519mNGS
Colorectal Neoplasms PRJNA1167935🔗3.42138658645428mNGS
Colorectal Neoplasms PRJNA1138893🔗4.01251017095309mNGS
Respiratory Syncytial Virus Infections PRJNA579491🔗-3.9441487619489816S
Lupus Erythematosus, Systemic PRJEB52971🔗-3.2609844314704116S
Lupus Erythematosus, Systemic PRJEB39044🔗3.2221286675219316S
Growth Disorders PRJEB39484🔗4.2107153750344516S
Hepatitis, Autoimmune PRJNA556801🔗3.5889137309559316S
Spinal Cord Injuries PRJNA861246🔗3.836600388650716S
Carcinoma, Renal Cell PRJNA842560🔗-3.4070130099038316S
Spondylarthritis PRJNA342486🔗3.2865273114832916S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.2731752193672516S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗3.9602395937540816S
Hidradenitis Suppurativa PRJEB43835🔗-3.3441851067478416S
Crohn Disease PRJNA909073🔗-3.682925915631816S
Crohn Disease PRJNA1156939🔗3.7986754631043716S
Polycystic Ovary Syndrome PRJEB38647🔗4.1437367755832216S
Schistosomiasis haematobia PRJNA526732🔗3.9615781544921816S
Diabetic Retinopathy PRJNA646010🔗3.4837089084221316S
Arthritis, Rheumatoid PRJNA574565🔗4.0470628068384116S
Anorexia Nervosa PRJEB11199🔗-4.1057600641240516S
Hematologic Neoplasms PRJNA777832🔗-3.5608591836494916S
Graves Ophthalmopathy PRJNA1089481🔗3.85645465039816S
Myasthenia Gravis PRJEB41297🔗-3.5837318130516716S
Liver Cirrhosis PRJNA861246🔗4.0480951677671516S
Diabetes Mellitus PRJNA774037🔗-4.5442198481732716S
HIV Infections PRJNA995875🔗-3.5972731445943516S
HIV Infections PRJNA762595🔗2.3276671982843516S
HIV Infections PRJDB11949🔗3.4045073728729816S
Autism Spectrum Disorder PRJNA917543🔗4.4660731651194316S
Multiple Sclerosis PRJEB53481🔗-3.5464282188035916S
Multiple Sclerosis PRJNA721421🔗2.7887305162851316S
Breast Neoplasms PRJNA658160🔗-4.0414957722985616S
COVID-19 PRJNA767939🔗-4.7189465412537316S
COVID-19 PRJNA769052🔗-3.6392218702249116S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Alloprevotella tannerae



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Alloprevotella tannerae



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Alloprevotella tannerae

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Alloprevotella_tannerae_ATCC_51259 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Alloprevotella tannerae


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Alloprevotella tannerae



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Alloprevotella tannerae

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Alloprevotella tannerae

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Alloprevotella tannerae

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Alloprevotella_tannerae_ATCC_51259 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Alloprevotella tannerae



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Alloprevotella tannerae


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Alloprevotella tannerae


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?